US Patent 11578372 NTRK1 fusion molecules and uses thereof
Patent 11578372 was granted and assigned to Foundation Medicine on February, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115783720
Date of Patent
February 14, 2023
0Patent Application Number
166835750
Date Filed
November 14, 2019
0Patent Citations
Patent Primary Examiner
Edits on 23 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 15 Feb, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+163 characters)
US Patent 11578372 NTRK1 fusion molecules and uses thereof
Article
Novel NTRK1 fusion molecules, detection reagents, and uses and kits for evaluating, identifying, assessing and/or treating a subject having a cancer are disclosed.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115783720
Date of Patent
February 14, 2023
0Patent Application Number
166835750
Date Filed
November 14, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11578372 NTRK1 fusion molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.